×
About 189,358 results

ALLMedicine™ Prostate Cancer Center

Research & Reviews  87,057 results

Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223.
https://doi.org/10.1016/j.clgc.2021.03.020
Clinical Genitourinary Cancer; Hijab A, Curcean S et. al.

May 7th, 2021 - Radium-223 is a bone-seeking, alpha-emitting radionuclide used in metastatic castration-resistant prostate cancer (mCRPC). Radium-223 increases the risk of fracture when used in combination with abiraterone and prednisolone. The risk of fracture i...

Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry i...
https://doi.org/10.1016/j.clgc.2021.03.021
Clinical Genitourinary Cancer; Lorenzo GD, Zappavigna S et. al.

May 7th, 2021 - Metastatic castration-resistant prostate cancer (mCRPC) is a deadly disease. Enzalutamide is an oral second-generation anti-androgen that is active in mCRPC. Circulating tumor cells (CTC) count correlates with overall survival (OS) in mCRPC, where...

Establishment and characterization of a novel treatment-related neuroendocrine prostate...
https://doi.org/10.1111/cas.14935
Cancer Science; Okasho K, Mizuno K et. al.

May 7th, 2021 - The prevalence of neuroendocrine prostate cancer (NEPC) arising from adenocarcinoma (AC) upon potent androgen receptor pathway inhibition is increasing. Deeper understanding of NEPC biology and development of novel therapeutic agents are needed. H...

Extraperitoneal Laparoscopic Versus Transperitoneal Robot-Assisted Laparoscopic Approac...
https://doi.org/10.1089/lap.2021.0174
Journal of Laparoendoscopic & Advanced Surgical Technique... Yıldız A, Anıl H et. al.

May 7th, 2021 - Background: We aim to directly compare the feasibility and safety of extended pelvic lymph node dissection (PLND) during transperitoneal robotic-assisted radical prostatectomy (Tp-RARP) and extraperitoneal laparoscopic radical prostatectomy (Ep-LR...

see more →

Guidelines  393 results

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 14th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
https://doi.org/10.1097/JU.0000000000001376
The Journal of Urology; Lowrance WT, Breau RH et. al.

Sep 22nd, 2020 - The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with castration-resistant disease. Please refer ...

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
https://doi.org/10.1097/JU.0000000000001375
The Journal of Urology; Lowrance WT, Breau RH et. al.

Sep 22nd, 2020 - The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with biochemical recurrence without metastatic di...

American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Relate...
https://doi.org/10.1016/j.prro.2020.06.009
Practical Radiation Oncology; Bauman GS, Jani AB

Sep 6th, 2020 - American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Related to Imaging Strategies for Advanced Prostate Cancer.|2020|Bauman GS,Jani AB,|

Optimizing the management of castration-resistant prostate cancer patients: A practical...
https://doi.org/10.1002/pros.24053
The Prostate REFERENCES; Shore ND, Drake CG et. al.

Aug 11th, 2020 - Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organizations ...

see more →

Drugs  341 results see all →

Clinicaltrials.gov  94,835 results

Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223.
https://doi.org/10.1016/j.clgc.2021.03.020
Clinical Genitourinary Cancer; Hijab A, Curcean S et. al.

May 7th, 2021 - Radium-223 is a bone-seeking, alpha-emitting radionuclide used in metastatic castration-resistant prostate cancer (mCRPC). Radium-223 increases the risk of fracture when used in combination with abiraterone and prednisolone. The risk of fracture i...

Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry i...
https://doi.org/10.1016/j.clgc.2021.03.021
Clinical Genitourinary Cancer; Lorenzo GD, Zappavigna S et. al.

May 7th, 2021 - Metastatic castration-resistant prostate cancer (mCRPC) is a deadly disease. Enzalutamide is an oral second-generation anti-androgen that is active in mCRPC. Circulating tumor cells (CTC) count correlates with overall survival (OS) in mCRPC, where...

Establishment and characterization of a novel treatment-related neuroendocrine prostate...
https://doi.org/10.1111/cas.14935
Cancer Science; Okasho K, Mizuno K et. al.

May 7th, 2021 - The prevalence of neuroendocrine prostate cancer (NEPC) arising from adenocarcinoma (AC) upon potent androgen receptor pathway inhibition is increasing. Deeper understanding of NEPC biology and development of novel therapeutic agents are needed. H...

Extraperitoneal Laparoscopic Versus Transperitoneal Robot-Assisted Laparoscopic Approac...
https://doi.org/10.1089/lap.2021.0174
Journal of Laparoendoscopic & Advanced Surgical Technique... Yıldız A, Anıl H et. al.

May 7th, 2021 - Background: We aim to directly compare the feasibility and safety of extended pelvic lymph node dissection (PLND) during transperitoneal robotic-assisted radical prostatectomy (Tp-RARP) and extraperitoneal laparoscopic radical prostatectomy (Ep-LR...

see more →

News  6,565 results

Many Americans Put Off Cancer Screenings Because of COVID-19
https://www.medscape.com/viewarticle/950227

Apr 29th, 2021 - (Reuters Health) - Nearly 10 million screenings for three common cancers were missed in the U.S. because of the COVID-19 pandemic, a new study suggests. A comparison of monthly screening rates during the spring and summer of 2020 to rates during 2...

A New Frontier in Papillary Thyroid Cancer Treatment
https://www.medscape.com/viewarticle/949688

Apr 25th, 2021 - A 73-year-old man with prostate cancer and hypertension came to see me for an incidental diagnosis of papillary thyroid microcarcinoma (PTMC). He had undergone fluorodeoxyglucose (FDG) PET with his oncology team because of a rising serum prostate-...

Loss of MAP3K7 and CHD1 Expression Drive Recurrence, Resistance in Prostate Cancer
https://www.medscape.com/viewarticle/949819

Apr 25th, 2021 - NEW YORK (Reuters Health) - Loss of MAP3K7 protein expression, seen in approximately 40% of prostate cancer patients, is a major driver of prostate tumor aggressiveness and should be considered for inclusion in management algorithms, researchers s...

AHA Statement Flags CV Risk of Hormonal Cancer Therapies
https://www.medscape.com/viewarticle/949979

Apr 25th, 2021 - Hormonal therapies for the treatment of hormone-dependent breast and prostate cancer could raise the risk for myocardial infarction (MI) and stroke, and patients need to be closely monitored to allow early detection and treatment of cardiovascular...

Healthy Lifestyle May Offset Genetic Risk in Prostate Cancer
https://www.medscape.com/viewarticle/949334

Apr 14th, 2021 - Adhering to a healthy lifestyle may offset the heightened risk of lethal prostate cancer in patients with adverse genetic risk factors, according to results of a large U.S. study. In men at the highest risk of dying from prostate cancer, having th...

see more →

Patient Education  167 results see all →